Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HCFC2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | VAMP8 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
mRNA | NIPA1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | PPP1R36 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | DUSP4 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | BROX | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | METTL16 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SGTB | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | PSD4 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |